Discovery and Structure–Activity Relationship of a Ryanodine Receptor 2 Inhibitor
Chemical and Pharmaceutical Bulletin · 2024
DOI: 10.1248/cpb.c24-00114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2024. Verfasst von Ryosuke Ishida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU). Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Calcium Channel Blockers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Ryanodine receptor 2 (RyR2) is a large Ca2+-release channel in the sarcoplasmic reticulum (SR) of cardiac muscle cells. It serves to release Ca2+ from the SR into the cytosol to initiate muscle contraction. RyR2 overactivation is associated with arrhythmogenic cardiac disease, but few specific inhibitors have been reported so far. Here, we identified an RyR2-selective inhibitor 1 from the chemical compound library and synthesized it from glycolic acid. Synthesis of various derivatives to investigate the structure-activity relationship of each substructure afforded another two RyR2-selective inhibitors 6 and 7, among which 6 was the most potent. Notably, compound 6 also inhibited Ca2+ release in cells expressing the RyR2 mutants R2474S, R4497C and K4750Q, which are associated with cardiac arrhythmias such as catecholaminergic polymorphic ventricular tachycardia (CPVT). This inhibitor is expected to be a useful tool for research on the structure and dynamics of RyR2, as well as a lead compound for the development of drug candidates to treat RyR2-related cardiac disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
- Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine.
Zitieren
APA
Ishida, R., Zeng, X., Kurebayashi, N., Murayama, T., Mori, S., & Kagechika, H. (2024). Discovery and Structure–Activity Relationship of a Ryanodine Receptor 2 Inhibitor. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c24-00114
Vancouver
Ishida R, Zeng X, Kurebayashi N, Murayama T, Mori S, Kagechika H. Discovery and Structure–Activity Relationship of a Ryanodine Receptor 2 Inhibitor. Chemical and Pharmaceutical Bulletin. 2024. doi:10.1248/cpb.c24-00114
BibTeX
@article{Ishida2024,
author = {Ishida, Ryosuke and Zeng, Xi and Kurebayashi, Nagomi and Murayama, Takashi and Mori, Shuichi and Kagechika, Hiroyuki},
title = {Discovery and Structure–Activity Relationship of a Ryanodine Receptor 2 Inhibitor},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2024},
doi = {10.1248/cpb.c24-00114}
}
EUVIMED